Trials / Terminated
TerminatedNCT03779828
Evaluating the Effectiveness of Telemonitoring System in the Management of Patients With CIDP
A Multicenter Pilot Study to Determine Criteria for Evaluating the Effectiveness of Two Comparative Monitoring Methods in the Management of Patients With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Receiving Home-based Treatment With IVIg (Privigen®)
- Status
- Terminated
- Phase
- —
- Study type
- Observational
- Enrollment
- 11 (actual)
- Sponsor
- CSL Behring · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
Chronic inflammatory demyelinating polyneuropathy (CIDP) is a chronic demyelinating polyneuropathy of autoimmune origin with a progressive or relapsing course. Diagnosis is based on clinical presentation and electrophysiological findings in accordance with the EFNS/PNS consensus guidelines. IVIg is the first line treatment witch has been shown to be effective in several placebo-controlled trials. Once IVIg therapy produces a response and is well tolerated, some patients are able to continue their treatment in the home setting. The HOME LINK system offers an integrated, global solution based on telemonitoring technology providing continuous, remote monitoring of Privigen® infusions administered at home.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | HOME LINK | Telemonitoring system which include web platform and connected devices. |
Timeline
- Start date
- 2017-11-27
- Primary completion
- 2019-06-03
- Completion
- 2019-06-03
- First posted
- 2018-12-19
- Last updated
- 2021-01-15
Locations
10 sites across 1 country: France
Source: ClinicalTrials.gov record NCT03779828. Inclusion in this directory is not an endorsement.